TakeAir

TakeAir is a private Belgian biotechnology and indoor-air-quality company focused on healthier indoor environments for commercial buildings. Its core offering, Biospheric Air Treatment, is installed as an add-on to existing HVAC systems and combines bio-based air treatment, pathogen reduction, microbial-balancing approaches, and sensor-enabled monitoring. The company positions its solution around improving indoor air quality, reducing airborne pathogen burden, lowering HVAC-related energy costs, and supporting ESG objectives for real-estate owners and operators. TakeAir appears to operate as a commercial-stage environmental health technology company rather than a drug developer, with deployments and pilot programs in office and real-estate settings. Its business is centered on built-environment biotechnology services, audits, and building-focused air-treatment systems rather than a traditional therapeutic pipeline.